Clinical Trial Update: Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and effectiveness of 1% tenofovir gel to prevent HIV-1 infection in women, and its effect on HSV-2 incidence; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Simplex Virus Infection

Drugs mentioned

• Tenofovir Gel (tenofovir disoproxil fumarate (topical gel))

Snippet

Sponsor: CONRAD | Conditions: HIV Prevention | Phase 3 | Status: COMPLETED